An 8-week Randomised, Double-blind Study to Compare the Fixed-dose Combination of Telmisartan 80 mg and; Amlodipine 10mg Versus Telmisartan 80 mg Monotherapy or Amlodipine 10 mg Monotherapy as First Line Therapy in Patients With Severe Hypertension (Grade 3).
Phase of Trial: Phase III
Latest Information Update: 12 Dec 2013
At a glance
- Drugs Amlodipine; Amlodipine/telmisartan; Telmisartan
- Indications Essential hypertension; Hypertension
- Focus Registrational; Therapeutic Use
- Acronyms TEAMSTA Severe HTN
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 24 Mar 2012 This trial is recruiting in Spain, Hungary and France.
- 13 Oct 2010 A Boehringer Ingelheim media release states the EMEA has approved telmisartan/amlodipine for the treatment of hypertension in adults.
- 31 Aug 2010 Results from this trial, presented at the 20th Scientific Society of Hypertension, were discussed at a briefing in Stockholm according to a Boehringer Ingelheim media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History